SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Arterial Vascular Engineering AVEI

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LevelHeaded who wrote (261)7/5/1998 11:52:00 PM
From: Jeffrey L. Henken  Read Replies (1) of 410
 
There are a lot posts about take over rumors concerning JNJ buying AVEI flying around over on the Yahoo thread again tonight. I would like to encourage everyone to pick up the phone or e mail AVE at the e mail address below and see what kind of answers you can get for yourselves.

It's true that JNJ has announced that they are looking at making an acquisition in the cardiovascular healthcare area. Could it be AVEI? I doubt it. Since when is AVE for sale? I don't think they are. Why?

Because AVEI has also announced that they are looking at 10 to 12 possible acquisition candidates. They are killing JNJ but they need to bundle their product just in case someone actually can produce a competitive stent. They also need to broaden their product line.

Go to the source people. ASK AVEI!

Are they interested in being acquired at any price?

How many possible acquisitions would they really make on their own?

Here is the phone number and an e mail address to the company.

Oh and would someone try to nail down that earnings date:

Phone: (707) 525-0111

jmiller@avei.com

Regards, Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext